Ott David C.

Transactions récentes

…

InsiderLens

USPersonne physique

Ott David C.

Transactions totales: 57
Entreprises: 13
Achats / Ventes: 21 / 10
Dernière transaction: 17 juin 2024

Transactions récentes

17 juin 2024SALEAPi Group Corp1 912 75038.15 USD
indirect· See Explanation of Responses
17 juin 2024SALEAPi Group Corp39 03238.15 USD
indirect· See Explanation of Responses
17 juin 2024SALEAPi Group Corp39 03238.15 USD
indirect· See Explanation of Responses
17 juin 2024SALEAPi Group Corp1 912 75038.15 USD
indirect· See Explanation of Responses
28 févr. 2024OTHERAPi Group Corp81 30036.90 USD
indirect· See Explanation of Responses
28 févr. 2024CONVERSIONAPi Group Corp164 01624.60 USD
indirect· See Explanation of Responses
28 févr. 2024CONVERSIONAPi Group Corp8 036 86224.60 USD
indirect· See Explanation of Responses
28 févr. 2024OTHERAPi Group Corp3 983 73936.90 USD
indirect· See Explanation of Responses
28 févr. 2024CONVERSIONAPi Group Corp4 0000.00 USD
indirect· See Explanation of Responsesderiv
28 févr. 2024CONVERSIONAPi Group Corp196 0000.00 USD
indirect· See Explanation of Responsesderiv
26 févr. 2024OTHERRayzeBio, Inc.1 743 556—
indirect· See Explanation of Responses
26 févr. 2024OTHERRayzeBio, Inc.4 899 144—
indirect· See Explanation of Responses
28 août 2023PURCHASEInhibrx, Inc.511 62719.35 USD
indirect· See Explanation of Responses
28 août 2023PURCHASEInhibrx, Inc.1 038 76519.35 USD
indirect· See Explanation of Responsesderiv
22 juin 2023SALERoivant Sciences Ltd.110 7569.90 USD
indirect· See Explanation of Responses
22 juin 2023SALERoivant Sciences Ltd.2 226 1959.90 USD
indirect· See Explanation of Responses
22 juin 2023SALERoivant Sciences Ltd.5 236 0069.90 USD
indirect· See Explanation of Responses
22 juin 2023SALERoivant Sciences Ltd.5 427 0439.90 USD
indirect· See Explanation of Responses
02 nov. 2022PURCHASEFrazier Lifesciences Acquisition Corp567 53210.08 USD
indirect· See Explanation of Responses
02 nov. 2022PURCHASEFrazier Lifesciences Acquisition Corp279 53010.08 USD
indirect· See Explanation of Responses
07 oct. 2022PURCHASEInhibrx, Inc.333 33330.00 USD
indirect· See Explanation of Responses
07 oct. 2022PURCHASEInhibrx, Inc.1 000 00030.00 USD
indirect· See Explanation of Responses
02 mars 2022OTHERGinkgo Bioworks Holdings, Inc.288 000 000—
indirect· See Explanation of Responses
02 mars 2022OTHERGinkgo Bioworks Holdings, Inc.288 000 000—
indirect· See Explanation of Responsesderiv
15 déc. 2020CONVERSION4D Molecular Therapeutics, Inc.2 004 581—
indirect· See Explanation Responses

…

17 juin 2024SALEAPi Group Corp1 912 75038.15 USD
indirect· See Explanation of Responses
17 juin 2024SALEAPi Group Corp39 03238.15 USD
indirect· See Explanation of Responses
17 juin 2024SALEAPi Group Corp39 03238.15 USD
indirect· See Explanation of Responses
17 juin 2024SALEAPi Group Corp1 912 75038.15 USD
indirect· See Explanation of Responses
28 févr. 2024OTHERAPi Group Corp81 30036.90 USD
indirect· See Explanation of Responses
28 févr. 2024CONVERSIONAPi Group Corp164 01624.60 USD
indirect· See Explanation of Responses
28 févr. 2024CONVERSIONAPi Group Corp8 036 86224.60 USD
indirect· See Explanation of Responses
28 févr. 2024OTHERAPi Group Corp3 983 73936.90 USD
indirect· See Explanation of Responses
28 févr. 2024CONVERSIONAPi Group Corp4 0000.00 USD
indirect· See Explanation of Responsesderiv
28 févr. 2024CONVERSIONAPi Group Corp196 0000.00 USD
indirect· See Explanation of Responsesderiv
26 févr. 2024OTHERRayzeBio, Inc.1 743 556—
indirect· See Explanation of Responses
26 févr. 2024OTHERRayzeBio, Inc.4 899 144—
indirect· See Explanation of Responses
28 août 2023PURCHASEInhibrx, Inc.511 62719.35 USD
indirect· See Explanation of Responses
28 août 2023PURCHASEInhibrx, Inc.1 038 76519.35 USD
indirect· See Explanation of Responsesderiv
22 juin 2023SALERoivant Sciences Ltd.110 7569.90 USD
indirect· See Explanation of Responses
22 juin 2023SALERoivant Sciences Ltd.2 226 1959.90 USD
indirect· See Explanation of Responses
22 juin 2023SALERoivant Sciences Ltd.5 236 0069.90 USD
indirect· See Explanation of Responses
22 juin 2023SALERoivant Sciences Ltd.5 427 0439.90 USD
indirect· See Explanation of Responses
02 nov. 2022PURCHASEFrazier Lifesciences Acquisition Corp567 53210.08 USD
indirect· See Explanation of Responses
02 nov. 2022PURCHASEFrazier Lifesciences Acquisition Corp279 53010.08 USD
indirect· See Explanation of Responses
07 oct. 2022PURCHASEInhibrx, Inc.333 33330.00 USD
indirect· See Explanation of Responses
07 oct. 2022PURCHASEInhibrx, Inc.1 000 00030.00 USD
indirect· See Explanation of Responses
02 mars 2022OTHERGinkgo Bioworks Holdings, Inc.288 000 000—
indirect· See Explanation of Responses
02 mars 2022OTHERGinkgo Bioworks Holdings, Inc.288 000 000—
indirect· See Explanation of Responsesderiv
15 déc. 2020CONVERSION4D Molecular Therapeutics, Inc.2 004 581—
indirect· See Explanation Responses